Delivery Order SPE2DR25D3401-SPE2DR26FL0VW
- Not listed
- The Defense Logistics Agency awarded a $3,616.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,233.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Actemra 162 mg/0.9 ml syringes. The contract, which represents a child order under a larger indefinite delivery vehicle, calls for completion by December 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $4,327.94 delivery order to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 mL auto-injector pens on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract specifies performance at...
- The Defense Logistics Agency (DLA) awarded a $7,842.98 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This non-set-aside, firm fixed price contract was executed on December 19, 2025, with completion scheduled for December 22, 2025. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $49,520.75 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml auto-injector pens. This firm fixed-price, non-set-aside contract is scheduled for completion by December 8, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,906.05 on September 22, 2025, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the contractor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector units. This firm fixed-price delivery order, valued at $6,863.64, represents a competitive award with no set-aside designation and is scheduled for completion by August 21, 2025. The award was issued to AmerisourceBergen's Corporate Office division, with performance to take place at the company's...
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml auto-injectors with a ceiling value of $8,352.14. This is a firm fixed-price order with an ultimate completion date of December 1, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing indefinite delivery contract (IDC) vehicle. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $15,566.22 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL injectable medication. This firm fixed-price delivery order, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation, and performance will be based at...
- The Defense Logistics Agency awarded a delivery order valued at $4,983.88 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL injections. This firm fixed price, competitively awarded delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract represents a pharmaceutical procurement to support federal medical supply needs, with performance to be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0VWDelivery Order
The Defense Logistics Agency awarded a $7,915.67 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml injectable medication. This is a firm fixed-price contract with an ultimate completion date of December 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract utilizes no set-aside designation, indicating competitive award to this established federal pharmaceutical vendor. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive $999.99 billion IDC with the Defense Logistics Agency (designated SPE2DX and extending through December 2026), which serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Actemra product supplied under this order is a immunosuppressive biologic used in treating rheumatoid arthritis and other inflammatory conditions, supporting military medical readiness and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 12/28/25 |